MCRB Q1 2026 Earnings EPS Misses Estimates Revenue Not Reported Stock Declines Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development BNR Q3 2022 Earnings EPS Beat Expectations Amid Challenging Operating Environment APEI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency RWTN Q1 2026 Earnings EPS Falls Short of Estimates but Shares Edge Higher ETR Q1 2026 Earnings Slight EPS Miss Amid Solid Utility Performance